Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium Wilfordii Tablets for Vocal Cord Leukoplakia
ChiCTR1900025914Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Jul 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Tripterygium wilfordii in Glottic laryngeal leukoplakia (6 arms), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoint: Area of vocal cord leukoplakia. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
Tripterygium wilfordii
03
Conditions
Glottic laryngeal leukoplakia
Beyond the preview
Go deeper on ChiCTR1900025914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025914.